MCMC
Matrix Capital Management Company Portfolio holdings
AUM
$223M
This Quarter Return
-6.64%
1 Year Return
-12.57%
3 Year Return
+145.82%
5 Year Return
+136.54%
10 Year Return
+717.06%
AUM
$8.34B
AUM Growth
+$8.34B
(-3.1%)
Cap. Flow
+$369M
Cap. Flow
% of AUM
4.43%
Top 10 Holdings %
Top 10 Hldgs %
90.96%
Holding
19
New
–
Increased
4
Reduced
–
Closed
–
Top Buys
| 1 |
Marvell Technology
MRVL
|
$251M |
| 2 |
Autodesk
ADSK
|
$61M |
| 3 |
Synopsys
SNPS
|
$49.6M |
| 4 |
ALTR
Altair Engineering Inc. Class A Common Stock
ALTR
|
$7.9M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 72.24% |
| 2 | Consumer Discretionary | 11.19% |
| 3 | Industrials | 11.07% |
| 4 | Healthcare | 5.09% |
| 5 | Materials | 0.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
NVIDIA
NVDA
$4.24T
| $1.38B | 16.51% | 3,163,700 | – | – |
|
2
GlobalFoundries
GFS
$18.5B
| $992M | 11.9% | 17,048,000 | – | – |
|
3
Applied Materials
AMAT
$128B
| $976M | 11.71% | 7,052,700 | – | – |
|
4
Amazon
AMZN
$2.44T
| $933M | 11.19% | 7,335,828 | – | – |
|
5
TransDigm Group
TDG
$78.8B
| $923M | 11.07% | 1,094,900 | – | – |
|
|
6
Marvell Technology
MRVL
$54.2B
| $713M | 8.55% | 13,166,824 +4,634,127 | +54% | +$251M |
|
|
ALTR
7
DELISTED
Altair Engineering Inc. Class A Common Stock
ALTR
| $707M | 8.48% | 11,300,457 +126,257 | +1% | +$7.9M |
|
8
Workday
WDAY
$61.6B
| $341M | 4.09% | 1,586,043 | – | – |
|
|
9
Synopsys
SNPS
$112B
| $329M | 3.95% | 717,735 +108,000 | +18% | +$49.6M |
|
10
ASML
ASML
$292B
| $293M | 3.51% | 497,200 | – | – |
|
11
Zentalis Pharmaceuticals
ZNTL
$122M
| $280M | 3.36% | 13,959,973 | – | – |
|
12
Qualcomm
QCOM
$173B
| $207M | 2.48% | 1,861,000 | – | – |
|
|
13
Autodesk
ADSK
$67.3B
| $85.7M | 1.03% | 414,000 +295,000 | +248% | +$61M |
|
14
Adaptive Biotechnologies
ADPT
$2.01B
| $63.1M | 0.76% | 11,572,590 | – | – |
|
15
Aura Biosciences
AURA
$389M
| $48.1M | 0.58% | 5,362,870 | – | – |
|
16
Perimeter Solutions
PRM
$3.28B
| $33.9M | 0.41% | 7,462,500 | – | – |
|
|
ADAP
17
Adaptimmune Therapeutics
ADAP
$15.6M
| $30.4M | 0.36% | 38,974,185 | – | – |
|
18
Ventyx Biosciences
VTYX
$171M
| $3.12M | 0.04% | 89,900 | – | – |
|
19
Zscaler
ZS
$43.1B
| $2.86M | 0.03% | 18,405 | – | – |
|